Bone Biologics Corp Warrants

Bone Biologics Corporation is a medical device company focused on bone regeneration in spinal fusion using a recombinant human protein in the United States. Its lead product is the NELL-1/DBM medical device, an osteopromotive recombinant protein that provides target-specific control over bone regeneration. The company also develops NB1, a NELL-1/DBM fusion device for lumbar spinal fusion, along with applications in spine implants, non-union trauma cases, and osteoporosis. It serves spine surgeons and patients with skeletal bone defects or bone-related conditions of the spine, and holds a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion via local administration, osteoporosis, and trauma applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.